These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31010566)

  • 21. A rat model for the study of transplacental pharmacokinetics and its assessment with antipyrine and aminoisobutyric acid.
    Varma DR; Ramakrishnan R
    J Pharmacol Methods; 1985 Aug; 14(1):61-74. PubMed ID: 4033137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodological Approaches to Evaluate Fetal Drug Exposure.
    Bouazza N; Foissac F; Hirt D; Urien S; Benaboud S; Lui G; Treluyer JM
    Curr Pharm Des; 2019; 25(5):496-504. PubMed ID: 30892158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal-fetal in vivo imaging: a combined PET and MRI study.
    Benveniste H; Fowler JS; Rooney WD; Moller DH; Backus WW; Warner DA; Carter P; King P; Scharf B; Alexoff DA; Ma Y; Vaska P; Schlyer D; Volkow ND; ;
    J Nucl Med; 2003 Sep; 44(9):1522-30. PubMed ID: 12960202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of drug disposition and effect in the fetus.
    Green TP; O'Dea RF; Mirkin BL
    Annu Rev Pharmacol Toxicol; 1979; 19():285-322. PubMed ID: 36829
    [No Abstract]   [Full Text] [Related]  

  • 25. Research goals in developmental pharmacology.
    Mirkin BL
    Clin Pharmacol Ther; 1973; 14(4):762-6. PubMed ID: 4737098
    [No Abstract]   [Full Text] [Related]  

  • 26. The fate of drugs in pregnancy.
    Mucklow JC
    Clin Obstet Gynaecol; 1986 Jun; 13(2):161-75. PubMed ID: 2873913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of steroids during pregnancy: Maternal, placental and fetal synthesis.
    Morel Y; Roucher F; Plotton I; Goursaud C; Tardy V; Mallet D
    Ann Endocrinol (Paris); 2016 Jun; 77(2):82-9. PubMed ID: 27155772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of developmental pharmacology and toxicology.
    Aranda JV; Stern L
    Pharmacol Ther; 1983; 20(1):1-51. PubMed ID: 6353435
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug effects on embryo and fetus. 2. Diaplacental transport of drugs].
    Reinhardt D; Richter O
    Fortschr Med; 1981 Sep; 99(35):1394-8. PubMed ID: 7274943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: The link between the mother and fetus in drug metabolism.
    Feuer G
    Rev Can Biol; 1973; 32():Suppl:113-21. PubMed ID: 4798225
    [No Abstract]   [Full Text] [Related]  

  • 31. Basic obstetric pharmacology.
    Zhao Y; Hebert MF; Venkataramanan R
    Semin Perinatol; 2014 Dec; 38(8):475-86. PubMed ID: 25281357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models for study of fetal drug exposure.
    Rudolph AM
    NIDA Res Monogr; 1985; 60():5-16. PubMed ID: 3932866
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic profile and placental transfer of a single intravenous injection of [(14)C]chlorpyrifos in pregnant rats.
    Abdel-Rahman AA; Blumenthal GM; Abou-Donia SA; Ali FA; Abdel-Monem AE; Abou-Donia MB
    Arch Toxicol; 2002 Aug; 76(8):452-9. PubMed ID: 12185413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations.
    Berezowska M; Sharma P; Pilla Reddy V; Coppola P
    Fundam Clin Pharmacol; 2024 Jun; 38(3):402-409. PubMed ID: 37968879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental transfer and fetal uptake of drugs.
    Welsch F
    J Vet Pharmacol Ther; 1982 Jun; 5(2):91-104. PubMed ID: 7109027
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats.
    Nirogi R; Bhyrapuneni G; Kandikere V; Muddana N; Saralaya R; Komarneni P; Mudigonda K; Mukkanti K
    Biopharm Drug Dispos; 2012 Jul; 33(5):265-77. PubMed ID: 22610784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
    Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of drug transfer across the placenta.
    Garland M
    Obstet Gynecol Clin North Am; 1998 Mar; 25(1):21-42. PubMed ID: 9547758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug transfer and metabolism by the human placenta.
    Syme MR; Paxton JW; Keelan JA
    Clin Pharmacokinet; 2004; 43(8):487-514. PubMed ID: 15170365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental drug transporters and their role in fetal protection.
    Iqbal M; Audette MC; Petropoulos S; Gibb W; Matthews SG
    Placenta; 2012 Mar; 33(3):137-42. PubMed ID: 22265855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.